MMP9 and central nervous system cancer: MMP-2 [81], MMP-9 [82,83], and MMP-14 [84] are particularly implicated in BBB degradation in gliomas, where their activity weakens tight junctions between endothelial cells and facilitates tumor invasion into the brain parenchyma.